AMPH Amphastar Pharmaceuticals Inc.

15.61
+0.83  (+6%)
Previous Close 14.78
Open 15.18
Price To Book 1.89
Market Cap 721,779,910
Shares 46,238,303
Volume 278,862
Short Ratio
Av. Daily Volume 266,081
Stock charts supplied by TradingView

NewsSee all news

  1. Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2019

    Reports Net Revenues of $83.4 Million for the Three Months Ended December 31, 2019 RANCHO CUCAMONGA, Calif., March 12, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the

  2. Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12th, 2020

    RANCHO CUCAMONGA, Calif., March 05, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its fourth quarter of 2019 ended December 31, 2019, after

  3. Amphastar Pharmaceuticals Receives FDA Approval for Supplement to its Abbreviated New Drug Application for Sodium Bicarbonate Injection, USP 8.4%, 50mEq/50mL

    RANCHO CUCAMONGA, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that the U.S. Food and Drug Administration ("FDA") granted approval of its supplemental

  4. Amphastar Announces the Receipt of a MINOR CRL for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial

    RANCHO CUCAMONGA, Calif., Jan. 28, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ:AMPH) announced that on January 24, 2020, the U.S. Food and Drug Administration ("FDA") issued a "MINOR" Complete

  5. Amphastar Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference

    RANCHO CUCAMONGA, Calif., Nov. 27, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President and Bill Peters, CFO will be presenting at the 31st Annual Piper

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Albuterol DPI
Asthma
CRL announced February 21, 2017.
Naloxone Intranasal
Opioid overdose
CRL issued December 27, 2016.
Primatene Mist (epinephrine inhalation aerosol)
Asthma

Latest News

  1. Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2019

    Reports Net Revenues of $83.4 Million for the Three Months Ended December 31, 2019 RANCHO CUCAMONGA, Calif., March 12, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the

  2. Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12th, 2020

    RANCHO CUCAMONGA, Calif., March 05, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its fourth quarter of 2019 ended December 31, 2019, after

  3. Amphastar Pharmaceuticals Receives FDA Approval for Supplement to its Abbreviated New Drug Application for Sodium Bicarbonate Injection, USP 8.4%, 50mEq/50mL

    RANCHO CUCAMONGA, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that the U.S. Food and Drug Administration ("FDA") granted approval of its supplemental

  4. Amphastar Announces the Receipt of a MINOR CRL for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial

    RANCHO CUCAMONGA, Calif., Jan. 28, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ:AMPH) announced that on January 24, 2020, the U.S. Food and Drug Administration ("FDA") issued a "MINOR" Complete

  5. Amphastar Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference

    RANCHO CUCAMONGA, Calif., Nov. 27, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President and Bill Peters, CFO will be presenting at the 31st Annual Piper

  6. Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

    RANCHO CUCAMONGA, Calif., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the Jefferies London Healthcare Conference

  7. Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2019

    Reports Net Revenues of $80.1 Million for the Three Months Ended September 30, 2019 RANCHO CUCAMONGA, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the

  8. Amphastar Pharmaceuticals to Present at the Wells Fargo 2019 Healthcare Conference

    RANCHO CUCAMONGA, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President, and Bill Peters, CFO, will be presenting at the Wells Fargo 2019